Fact-checked by Grok 2 weeks ago

Hydronephrosis

Hydronephrosis is a medical condition characterized by the swelling or dilation of one or both kidneys due to the backup of urine, typically resulting from an obstruction in the urinary tract that prevents normal urine flow from the kidney to the bladder. This obstruction can occur at various points, leading to increased pressure within the renal pelvis and calyces, which may impair kidney function if untreated. The condition can be acute or chronic, unilateral or bilateral, and may arise from intrinsic factors within the urinary system or extrinsic compression from surrounding structures. Common causes of hydronephrosis include kidney stones, blood clots, tumors, or structural abnormalities such as ureteropelvic junction obstruction, particularly in children. In adults, in older males or pregnancy-related compression in females are frequent contributors, with approximately 90% of pregnant women experiencing some degree of hydronephrosis due to uterine pressure on the ureters. Congenital anomalies account for many pediatric cases; for example, posterior urethral valves occur in male infants at an incidence of approximately 1 in 5,000 to 8,000 live births, while congenital urinary tract defects more broadly affect about 1% of newborns . Other etiologies encompass infections, neurogenic , or . Symptoms of hydronephrosis are often absent in mild or early stages, but when present, they may include dull flank pain, painful urination (dysuria), nausea, vomiting, frequent urinary tract infections, or blood in the urine (hematuria). In severe cases, especially bilateral involvement, it can lead to complications like acute kidney injury, chronic kidney disease, or even kidney failure due to prolonged pressure reducing glomerular filtration and causing tubular damage. Diagnosis typically begins with a and , followed by studies such as renal to detect , which is the preferred initial test due to its non-invasive nature. Additional tests may include computed (CT) urography for detailed , and analyses to assess function and rule out or stones, or scans like MAG3 to evaluate drainage. Prenatal often identifies the condition in fetuses, allowing for early postnatal management. Treatment focuses on relieving the obstruction, draining excess , and addressing the underlying cause to prevent permanent damage. Options include medications for or , temporary urinary drainage via catheters, stents, or tubes, and surgical interventions such as for stones or prostate for benign . In newborns with mild congenital hydronephrosis, close monitoring with serial ultrasounds may suffice, as many cases resolve spontaneously by 18 months. Early intervention is critical to preserve renal function and avoid long-term complications.

Overview

Definition

Hydronephrosis is defined as the dilatation and distension of the renal collecting system, including the renal pelvis and calyces, resulting from the obstruction of urine outflow distal to these structures, which leads to the accumulation of urine within the kidney. This condition represents a structural abnormality rather than a primary disease, typically arising secondary to an underlying obstruction that impairs the normal drainage of urine. In normal renal , urine produced by the nephrons within the kidney drains into the minor calyces, which converge to form the major calyces; these then empty into the , a funnel-shaped structure that funnels into the for transport to the . Obstructions causing hydronephrosis can occur at various points along this pathway, such as the ureteropelvic junction (UPJ)—the site where the connects to the proximal —or further along the , leading to upstream backup of and progressive dilation of the collecting system. Hydronephrosis can be classified based on its extent and duration, including unilateral involvement of a single or bilateral affecting both kidneys, as well as acute presentations that develop rapidly or chronic forms that progress gradually over time. Unilateral hydronephrosis often stems from localized obstructions, while bilateral cases may involve more distal blockages impacting both ureters.

Epidemiology

Hydronephrosis is detected prenatally in approximately 1 in 100 to 1 in 500 pregnancies through routine screening, representing one of the most common fetal anomalies identified during . In adults, the condition occurs in about 1 in 100 individuals at some point, often incidentally on imaging studies, though symptomatic cases are less frequent. These figures vary by underlying , with congenital forms predominating in neonates and acquired obstructions more common in older populations. Demographic patterns show hydronephrosis is more prevalent in males during the neonatal period, primarily due to congenital obstructions like posterior urethral valves, with boys affected four to five times more often than girls. Incidence peaks again in adults aged 20 to 60 years, where it is more common in women owing to pregnancy-related physiological changes and gynecologic conditions, while in men over 60, emerges as a leading cause. Key risk factors include , where physiological hydronephrosis affects up to 90% of women due to uterine compression on the ureters, typically resolving postpartum. Other contributors encompass recurrent urinary tract infections, which can lead to scarring and obstruction, and diabetes mellitus, which heightens the risk of stone formation as a precipitating factor. A family history of congenital urinary tract anomalies also elevates susceptibility, particularly for neonatal cases. Detection rates have risen since the with the widespread adoption of prenatal , identifying hydronephrosis in 1% to 3% of pregnancies and enabling earlier interventions that improve outcomes. As of recent data through 2025, overall incidence remains stable, but enhanced screening has shifted focus toward for mild cases, reducing unnecessary procedures.

Clinical Presentation

Signs and Symptoms

Hydronephrosis often presents with a range of symptoms related to urinary obstruction, though the condition can vary widely in its manifestations depending on the underlying cause and duration. Common symptoms include flank or , which may be colicky and intermittent if associated with conditions like kidney stones, or a constant dull ache in cases of gradual obstruction. , or blood in the urine, painful or urgent , and are also frequently reported, often stemming from or incomplete emptying of the urinary tract. Accompanying gastrointestinal symptoms such as and may occur, particularly when pain is severe. A significant proportion of hydronephrosis cases, especially mild or forms, are and discovered incidentally through or prenatal screening. In acute presentations, symptoms tend to be more abrupt and intense, including sudden severe flank pain and reduced urine output (), reflecting rapid buildup of pressure in the . hydronephrosis, by contrast, often features a persistent dull ache in the flank or back, with symptoms developing insidiously over time due to ongoing obstruction. In pediatric patients, manifestations differ by age and severity. Infants with hydronephrosis may exhibit poor feeding, , or a swollen in severe cases, while older children might experience or recurrent urinary tract infections alongside general symptoms like . Prenatal hydronephrosis is particularly common and often asymptomatic postnatally, resolving spontaneously in many instances without intervention.

Associated Conditions

Hydronephrosis is frequently associated with urinary tract infections (UTIs) due to urinary , which promotes bacterial and increases the risk of ascending infection to the kidneys, potentially leading to . in this context manifests with systemic symptoms including fever, chills, flank pain, and , particularly in infants and young children with severe hydronephrosis. The interplay is bidirectional, as untreated infections can worsen renal by causing and further obstruction. Urolithiasis, or kidney stones, commonly coexists with hydronephrosis, where stones lodged in the can precipitate acute obstructive episodes, exacerbating renal swelling. These stones are typically composed of or , with calcium-based varieties accounting for the majority of cases. The presence of hydronephrosis in patients with urolithiasis heightens the risk of complications such as , especially when combined with concurrent infections. Congenital anomalies of the urinary tract, such as (VUR) and posterior urethral valves (PUV), are significant comorbidities in pediatric hydronephrosis cases. VUR involves retrograde urine flow from the to the ureters and kidneys, occurring in 10-20% of neonatal hydronephrosis and promoting recurrent infections that perpetuate dilation. PUV, a male-specific characterized by obstructing urethral folds, frequently results in bilateral hydronephrosis detected antenatally in approximately 35-40% of cases, often accompanied by VUR in about 50% of affected individuals due to elevated pressures. These anomalies can lead to long-term renal impairment if the associated hydronephrosis is severe. Pregnancy-related hydronephrosis is a transient condition affecting up to 90% of pregnant individuals, primarily due to mechanical compression of the by the enlarging , with a right-sided predominance owing to the anatomical position of the protecting the left ureter. This physiologic dilation typically emerges in the second , resolves spontaneously within 6-12 weeks postpartum, and is usually , though it may increase UTI susceptibility during . These associated conditions can intensify baseline symptoms of hydronephrosis, such as flank pain from stone passage or infection.

Etiology and Pathophysiology

Causes

Hydronephrosis results from obstructions that impede urine flow from the to the , leading to dilation of the and calyces. These obstructions can be classified as intrinsic, extrinsic, or iatrogenic, with the specific cause influencing whether the condition is unilateral or bilateral. Intrinsic causes originate within the urinary tract itself. Common examples include ureteropelvic junction (UPJ) obstruction, often congenital due to narrowing at the junction of the and , affecting approximately 1 in 1,000–2,000 live births. Ureteral strictures, resulting from , , or prior , narrow the and block flow. Bladder outlet obstruction, such as (BPH) in males, prevents complete emptying of the , causing upstream pressure and dilation. Other intrinsic factors encompass ureteral stones, posterior urethral valves in infants, and . Extrinsic causes involve compression from structures outside the urinary tract. Pelvic tumors, such as those of the , , colon, or , can externally compress the . , a rare condition involving inflammatory scarring in the retroperitoneum, encases and obstructs the . In , the gravid often compresses the , particularly on the right side, affecting up to 80% of pregnant women, though it typically resolves postpartum. Additional extrinsic factors include peripelvic cysts, retrocaval ureter, and . Iatrogenic causes arise from medical interventions. Post-surgical scarring or strictures following pelvic or abdominal procedures can narrow the . Accidental injury to the during , radiation therapy-induced , or blood clots from procedures may also obstruct flow. Unilateral hydronephrosis is more prevalent, often stemming from single-site issues like UPJ obstruction, ureteral stones, or localized tumors, accounting for about 88-89% of cases in studied populations. Bilateral hydronephrosis, seen in roughly 11-12% of cases, frequently results from distal obstructions such as bladder neck issues (e.g., BPH) or bilateral stones, leading to symmetric involvement.

Pathophysiology

Hydronephrosis arises from urinary tract obstruction, which elevates intraluminal pressure within the and calyces, leading to progressive of the collecting system. This increased hydrostatic pressure transmits back to the , compressing the pyramids and , thereby reducing the functional renal tissue volume. In cases of mid-al obstruction, such as from calculi or strictures, the pressure buildup extends downstream, causing of the ureter known as hydroureter. The pathophysiological progression occurs in distinct stages, beginning with reversible of the collecting system in acute obstruction, where prompt can restore normal anatomy and function. Prolonged obstruction, however, triggers irreversible structural changes, including tubular atrophy characterized by flattened and dilated lumens, interstitial fibrosis with deposition, and glomerular sclerosis involving scarring of the filtration units. These alterations stem from ischemia, , and activation of profibrotic pathways, ultimately leading to loss. Functionally, obstruction rapidly impairs (GFR) due to elevated intratubular pressure opposing filtration forces, with significant declines observable within hours. Additionally, chronic obstruction activates the intrarenal renin-angiotensin system, increasing renin secretion from compressed juxtaglomerular cells and promoting , which exacerbates and further renal injury.

Diagnosis

Clinical Evaluation

The clinical evaluation of suspected hydronephrosis begins with a detailed to identify potential obstructive causes and assess symptom severity. Clinicians inquire about the onset and character of , which may present as acute, colicky flank or abdominal discomfort due to distension of the or intermittent ureteral obstruction, or as a chronic dull ache from gradual urine backup. Urinary symptoms are also elicited, including , urinary frequency, urgency, hesitancy, or , which suggest underlying , stones, or lower tract involvement. In women, obstetric is crucial, as pregnancy-related hydronephrosis often arises from mechanical compression by the gravid uterus, particularly in the third trimester, and may be exacerbated by multiparity or prior cesarean sections. Additionally, recent medical procedures, such as urologic instrumentation, pelvic surgery, or lithotripsy, are reviewed, as these can lead to iatrogenic strictures or edema causing obstruction. Physical examination focuses on detecting signs of renal involvement and systemic effects. often reveals on the affected side, reflecting capsular or , though patients may shift uncomfortably due to pain. In severe or chronic cases, a palpable abdominal or flank mass may be appreciated, representing the dilated , especially in children or with giant hydronephrosis. can emerge in bilateral or longstanding obstruction due to activation of the renin-angiotensin system from renal ischemia, warranting . For men, a may assess prostate enlargement, while in women, a pelvic exam evaluates for uterine or adnexal . Laboratory tests provide initial insights into renal function and potential complications. is essential to detect indicative of stones or tumors, or suggesting , and pointing to urolithiasis as the obstructing cause. and levels assess and help gauge the degree of from post-renal obstruction, with elevations signaling significant impairment. A is performed to identify , which may indicate an associated or systemic inflammatory response. Differential diagnosis during evaluation emphasizes distinguishing hydronephrosis from other causes of flank or through targeted . is ruled out by the absence of right lower quadrant localization, anorexia, or rebound tenderness, as typically radiates to the without peritoneal signs. In reproductive-age women, is excluded by confirming intrauterine gestation via and negative beta-hCG if applicable, particularly when pain mimics adnexal pathology. These elements guide suspicion for hydronephrosis prior to confirmatory studies.

Imaging Studies

Renal ultrasound serves as the first-line imaging modality for diagnosing hydronephrosis due to its non-invasive nature, lack of ionizing radiation, and ability to detect renal pelvic dilation effectively. It is particularly sensitive for identifying moderate to severe hydronephrosis, with reported sensitivities exceeding 90% in cases associated with ureteral obstruction, such as stones. This technique visualizes the renal pelvis, calyces, and ureters, allowing assessment of dilation severity and potential causes like pelviureteric junction obstruction, while also evaluating parenchymal thickness and echogenicity for signs of dysplasia. For more detailed evaluation, particularly when ultrasound findings are equivocal or the underlying cause requires precise localization, advanced imaging techniques are employed. Computed tomography (CT) urography, involving contrast-enhanced CT scans, is highly effective for detecting etiologies such as urinary tract stones, tumors, or strictures, offering superior sensitivity compared to ultrasound for ureteral pathologies. Magnetic resonance imaging (MRI), including MR urography, is preferred in specific scenarios like pregnancy or contrast allergies, providing detailed anatomical and functional information without radiation exposure, though its clinical utility in acute obstruction remains under evaluation. Nuclear scintigraphy, such as the mercaptoacetyltriglycine (MAG3) renal scan with diuretic challenge, assesses renal function and differentiates obstructive from non-obstructive dilation by measuring washout times, with values under 15 minutes indicating no significant obstruction. Prenatal detection of hydronephrosis occurs via fetal , typically in the second , using anteroposterior pelvic diameter measurements (≥4 mm in the second or ≥7 mm in the third) to identify dilation early and guide postnatal management. This approach allows for timely intervention in severe cases, such as those with suggesting lower urinary tract obstruction. Despite its advantages, renal ultrasound is operator-dependent, with interobserver variability affecting interpretation, and may yield false positives in up to 25% of minimal cases. urography carries risks of , particularly concerning in pediatric or pregnant patients, limiting its routine use. According to American College of Radiology appropriateness criteria, with color Doppler is usually appropriate as an initial study for symptomatic hydronephrosis, while advanced modalities like MAG3 or MR urography are rated highly for functional assessment in complex cases.

Grading

Hydronephrosis severity is classified using standardized systems based on imaging findings to assess anatomical dilation and parenchymal involvement, primarily through , which serves as the initial diagnostic modality. These classifications help differentiate mild cases suitable for from severe ones requiring closer or . The Society for Fetal Urology (SFU) grading system, introduced in 1993, is widely used for prenatal and postnatal evaluation of hydronephrosis in children. It categorizes severity on a scale from grade 0 (normal, no dilation with opposed calyceal walls) to grade 4 (gross dilation of the and calyces with parenchymal and ). Specifically, grade 1 indicates mild renal pelvic dilation without calyceal involvement; grade 2 shows mild pelvic and calyceal dilation with preserved pelvicalyceal architecture and no parenchymal ; grade 3 involves moderate dilation of the pelvis and all calyces with blunted fornices but minimal cortical ; and grade 4 features severe ballooning of the collecting system with significant loss of parenchymal thickness. This system is particularly applied in fetal and pediatric contexts to standardize reporting and track progression. A more recent multidisciplinary , the Urinary Tract (UTD) system, introduced in 2014 and updated in 2021, standardizes evaluation of prenatal (A1-3) and postnatal (P1-3) urinary tract , including hydronephrosis. It assesses of the kidney (UTD P1: only; P2: pelvis and few calyces; P3: pelvis, calyces, and parenchymal thinning), (UTD U1-3), (UTD B1-2), and posterior (UTD C), allowing for a comprehensive risk stratification beyond isolated renal findings. The UTD system is recommended by the for perinatal management as of 2025. In adults, hydronephrosis is often graded qualitatively using criteria similar to pediatric systems but simplified into mild, moderate, and severe categories to reflect clinical relevance. Mild hydronephrosis involves isolated pelvic without calyceal involvement or parenchymal loss; moderate includes extending to the calyces with preserved renal ; and severe encompasses marked pelvicalyceal accompanied by cortical thinning or . These distinctions aid in correlating anatomical changes with potential functional impairment. Functional grading complements anatomical assessment through diuretic renography, which evaluates renal drainage and differential function to confirm obstruction. In this study, using agents like technetium-99m-MAG3, obstruction is indicated by delayed washout after administration, with differential renal function below 40% on the affected side signifying significant impairment and potential need for . This threshold helps distinguish obstructive from non-obstructive , particularly in equivocal cases. These grading systems provide clinical utility by informing prognosis and management thresholds; for instance, SFU grades 3-4 or UTD P3 or equivalent severe adult classifications often prompt surgical consideration if associated with functional deterioration, whereas lower grades typically allow conservative follow-up.

Management

Conservative Measures

Conservative management of hydronephrosis focuses on non-invasive strategies for mild or asymptomatic cases, particularly those detected antenatally or postnatally without significant renal impairment. For prenatal hydronephrosis classified as mild (anteroposterior pelvic diameter [APD] less than 10 mm or Society for Fetal Urology [SFU] grade 1-2), observation with serial renal ultrasounds is the standard approach, typically initiated postnatally at 4-6 weeks, followed by intervals of 3-6 months and then 6-12 months until resolution or stabilization. This watchful waiting allows for spontaneous improvement, with 80-90% of mild cases resolving without intervention by infancy. In postnatal cases of suspected ureteropelvic junction obstruction with preserved renal function, similar monitoring with ultrasounds every 6-12 months is recommended for at least 2 years to assess for spontaneous resolution before considering escalation. Pain associated with hydronephrosis, often due to acute obstruction from stones causing , is primarily managed with non-steroidal anti-inflammatory drugs (NSAIDs) such as or ibuprofen as first-line therapy, which provide effective analgesia comparable to or superior to opioids while reducing the risk of side effects like . Opioids, such as , may be reserved for severe cases refractory to NSAIDs, often in combination for enhanced relief during acute episodes. To prevent or treat urinary tract infections (UTIs) complicating hydronephrosis, especially in children with vesicoureteral reflux or high-grade dilation, antibiotic prophylaxis is employed using agents like nitrofurantoin (1-2 mg/kg daily) or trimethoprim-sulfamethoxazole, which reduce UTI recurrence rates in at-risk pediatric populations. Acute UTIs require targeted antibiotics based on culture sensitivity, with prophylaxis continued until resolution of the underlying obstruction or dilation. Lifestyle modifications play a supportive role, particularly in hydronephrosis secondary to urolithiasis, where increased fluid intake (aiming for 2-3 liters daily in adults) promotes urine dilution and prevents stone formation or recurrence. For distal ureteral stones contributing to obstruction, alpha-blockers such as tamsulosin (0.4 mg daily) facilitate stone passage by relaxing ureteral , increasing expulsion rates by 20-30% in conservative therapy.

Interventional Treatments

Interventional treatments for hydronephrosis focus on relieving urinary tract obstruction to preserve renal function and addressing the underlying through minimally invasive or surgical procedures. The selection of intervention is influenced by the obstruction's location, severity, and patient factors, with temporary often prioritized in acute cases to prevent irreversible damage. Temporary relief is commonly achieved via ureteral stenting or percutaneous nephrostomy. Ureteral stenting involves cystoscopic placement of a double-J stent to bypass the obstruction and facilitate urine drainage from the kidney to the bladder, effectively decompressing the system in most cases. This procedure is preferred for its retrograde access and lower risk of infection compared to percutaneous methods. Percutaneous nephrostomy, performed under ultrasound or fluoroscopic guidance, entails inserting an 8-12 French catheter directly into the renal pelvis through the skin to drain urine externally, achieving complete decompression in 66% and partial decompression in 32% of cases in infants and young children. It is indicated when retrograde stenting fails or in patients with severe infection or anatomical challenges. Cause-specific interventions target the primary obstruction. For urolithiasis, extracorporeal shock wave lithotripsy (ESWL) delivers focused shock waves to fragment ureteral stones, promoting passage and resolving hydronephrosis without incision, with success rates unaffected by mild to moderate hydronephrosis degree in distal stones. Ureteropelvic junction (UPJ) obstruction is corrected by pyeloplasty, a that excises the narrowed segment and reanastomoses the to the , often laparoscopically to minimize recovery time. In (BPH), (TURP) removes obstructing prostate tissue endoscopically, alleviating bladder outlet obstruction and associated upper tract dilation. Advanced procedures address complex or recurrent obstructions. Endoscopic ureterotomy, using or incision tools under ureteroscopy, treats benign ureteral strictures by incising fibrotic tissue to restore patency, with success rates up to 70% for short strictures less than 2 . For malignant causes, such as extrinsic from pelvic tumors, options include surgical tumor resection to remove the obstructing mass or systemic to shrink the tumor and relieve pressure, often combined with stenting for immediate . In pediatric patients, posterior urethral valves—a congenital cause of obstruction—are managed by endoscopic valve via , which incises the valvular tissue to restore urethral flow. Timing varies: neonatal is pursued in severe cases with respiratory or renal compromise, while delayed intervention (post-1 year) may suffice in stable infants, potentially reducing long-term renal insufficiency risk. The urgency of these interventions is often guided by hydronephrosis grading to prevent progression to renal impairment.

Prognosis

Short-Term Outcomes

The resolution of hydronephrosis and of renal after of obstruction depend on the duration and severity, with full possible if relieved within weeks of onset but beyond that. In prenatal or antenatal hydronephrosis, many cases improve spontaneously without , with rates exceeding 80% for mild grades during the neonatal period. For instance, ureteral stenting or percutaneous tube placement, as part of conservative or interventional management, often leads to rapid and subsequent normalization of pelvic dilation in these scenarios. Early complications after treatment, particularly with ureteral stenting, include infections in approximately 5% of cases, with pain reported in 20-80% and (bleeding) being common but often mild. These risks are more pronounced in obstructed systems with preexisting urinary tract infections, where biofilm formation on stents can contribute to bacterial , though symptomatic infections remain relatively low. Success in short-term outcomes is measured by of renal , often evidenced by a drop in serum levels within days of , and prompt relief of symptoms such as flank pain or . In acute presentations, can recover rapidly, often within days, restoring baseline in most uncomplicated cases. Acute hydronephrosis responds more favorably in the short term compared to forms, where parenchymal may limit rapid , and bilateral involvement portends worse immediate outcomes due to higher risks of and systemic effects.

Long-Term Effects

Untreated or recurrent hydronephrosis can result in significant renal damage, particularly through prolonged urinary obstruction that leads to tubular atrophy, interstitial fibrosis, and eventual (CKD). Untreated hydronephrosis contributes to approximately 5-10% of end-stage renal disease cases, particularly in congenital forms, though early management reduces this risk significantly. In severe cases, this damage affects kidney function irreversibly if not addressed, with end-stage renal disease occurring rarely when the condition is managed promptly. Systemic complications arise from the chronic renal ischemia and associated with hydronephrosis, including driven by increased renin release from the affected . This activates the renin-angiotensin-aldosterone system (RAAS), causing , sodium retention, and elevated , as observed in cases of giant hydronephrosis where resolves post-intervention. Additionally, urinary stasis predisposes patients to recurrent urinary tract infections (UTIs), which can exacerbate renal scarring and further impair function. In pediatric patients, bilateral hydronephrosis poses unique long-term risks, including growth impairment due to chronic dysfunction and associated , particularly in severe or unmanaged cases. These children require lifelong monitoring with serial ultrasounds and functional assessments to detect progression and prevent complications like recurrent UTIs or worsening renal impairment. Recent studies as of 2025 emphasize improved long-term outcomes with early detection of hydronephrosis, such as through anteroposterior diameter measurements in neonates, which facilitate timely interventions and reduce the risk of progression to CKD by enabling spontaneous resolution in a majority of mild cases. Integrated care models have further enhanced diagnostic accuracy and expedited treatment, minimizing chronic sequelae.

References

  1. [1]
    Hydronephrosis - Symptoms and causes - Mayo Clinic
    Nov 6, 2024 · Hydronephrosis is swelling of one or both kidneys. It happens when urine can't drain from a kidney and builds up in the kidney as a result.
  2. [2]
    Hydronephrosis and Hydroureter - StatPearls - NCBI Bookshelf - NIH
    Hydronephrosis is defined as dilatation and distension of the renal collecting system of one or both kidneys due to obstruction of urine outflow distal to the ...Introduction · Epidemiology · Evaluation · Treatment / Management
  3. [3]
    Hydronephrosis - Diagnosis and treatment - Mayo Clinic
    Nov 6, 2024 · The goal of treatment is to ease kidney swelling and prevent kidney damage. You may need medicine, a process to drain urine or surgery.Missing: definition | Show results with:definition
  4. [4]
    Bilateral hydronephrosis: MedlinePlus Medical Encyclopedia
    Apr 1, 2025 · Bilateral hydronephrosis occurs when urine is unable to drain from the kidney into the bladder. Hydronephrosis is not itself a disease.Missing: definition | Show results with:definition
  5. [5]
    Anatomy, Abdomen and Pelvis: Kidneys - StatPearls - NCBI Bookshelf
    Sep 15, 2025 · Major calyces subsequently unite to form the renal pelvis, a funnel-shaped structure that marks the transition to the proximal ureter.[25] ...
  6. [6]
    Ureteropelvic Junction Obstruction - StatPearls - NCBI Bookshelf - NIH
    Ureteropelvic junction obstruction (UPJO) is one of the most common causes of hydronephrosis in children. If it is left untreated, it might cause loss of the ...Continuing Education Activity · Etiology · Evaluation · Treatment / Management
  7. [7]
    Hydronephrosis of one kidney: MedlinePlus Medical Encyclopedia
    Mar 31, 2024 · Hydronephrosis is swelling of one kidney due to a backup of urine. This problem may occur in one kidney.
  8. [8]
    Prenatal hydronephrosis - PubMed
    Prenatal hydronephrosis is diagnosed with an incidence of 1:100 to 1:500 maternal-fetal ultrasonographic studies. Although ultrasonography accurately ...
  9. [9]
    Hydronephrosis - The Fetal Medicine Foundation
    Prevalence: 1 in 500 births. Ultrasound diagnosis: Dilatation of the collecting system of the kidney observed in the standard transverse view of the abdomen ...
  10. [10]
    Hydronephrosis: Causes, Symptoms, Diagnosis & Treatment
    It occurs in about 1 in 100 adults at some point in their life. In infants, it's often due to an obstruction (blockage) that happens during fetal development ( ...Missing: demographics | Show results with:demographics
  11. [11]
    Hydronephrosis | Denver Urology Associates | Lone Tree
    It is not uncommon, occurring in 1 in 100 adults at some time in their lives. It also occurs fairly frequently in infants either before birth (prenatal ...
  12. [12]
    Hydronephrosis and Hydroureter - Medscape Reference
    Oct 30, 2024 · At age 20-60 years, hydronephrosis was more common in women, possibly because of pregnancy and gynecologic malignancy. In men, prostatic ...
  13. [13]
    Hydronephrosis | UNC Department of Urology
    To date, there are no known risk factors for hydronephrosis. However, boys are four-to-five times more likely to be born with hydronephrosis than girls.Missing: demographics | Show results with:demographics
  14. [14]
    Etiology of Hydronephrosis in adults and children - NIH
    Hydronephrosis (HN) is dilatation of the collecting system of the kidney due to obstruction of urine outflow. This study intended firstly, to investigate ...Missing: symptoms | Show results with:symptoms
  15. [15]
    Maternal hydronephrosis in pregnancy | Radiology Reference Article
    Jul 21, 2023 · It is estimated that up to 90% of women have some degree of asymptomatic dilatation of the renal calyces, the renal pelves and the upper two-thirds of the ...
  16. [16]
    Hydronephrosis | National Kidney Foundation
    Hydronephrosis can occur in one or both kidneys. Over time, kidney function can decrease, leading to possible kidney damage. Signs and symptoms.
  17. [17]
    Congenital Anomalies of the Kidneys and Urinary Tract
    A family history of kidney or urinary tract problems may increase the risk of a baby being born with one of these anomalies, but in most cases the cause of ...
  18. [18]
    Perinatal Urinary Tract Dilation: Recommendations on Pre ...
    Jun 16, 2025 · In the 1980s, the properties of fetal ultrasonography (US) afforded the discovery of hydronephrosis in 1% to 3% of pregnancies, which led to a ...
  19. [19]
    Hydronephrosis in Newborns - NIDDK
    Hydronephrosis in newborns is enlargement, or dilation, of the renal pelvis—the basin in the central part of the kidney where urine collects ...
  20. [20]
    Kidney Stones: Causes, Symptoms, Diagnosis & Treatment
    Kidney stones can put you at risk for: A blockage that backs pee up into your kidney, causing it to swell (hydronephrosis). Kidney infection (pyelonephritis).Hydronephrosis · Kidney Stones Treatment · Kidney Cysts · Uric Acid Stones
  21. [21]
    Ureteral stone with hydronephrosis and urolithiasis alone are risk ...
    The presence of ureteral stone with hydronephrosis increases the risk for AKI of UTI patients with urolithiasis, and urolithiasis remains a risk factor of AKI ...
  22. [22]
    Posterior Urethral Valves - StatPearls - NCBI Bookshelf
    Posterior urethral valves are a rare congenital disorder affecting the male urinary tract, characterized by abnormal membranous folds in the posterior urethra.
  23. [23]
    Hydronephrosis is associated with elevated plasmin in urine in ...
    Sep 1, 2018 · It is concluded that the RAAS contributes to hypertension following partial obstruction of urine flow at the pelvo-ureteric junction with ...
  24. [24]
    Acute Abdominal Pain in Adults: Evaluation and Diagnosis - AAFP
    The most common causes are gastroenteritis and nonspecific abdominal pain, followed by cholelithiasis, urolithiasis, diverticulitis, and appendicitis.
  25. [25]
    Abdominal Pain in Pregnancy: Diagnoses and Imaging Unique to ...
    This article reviews the causes of abdominal pain that are unique to pregnancy as well as some of the more common and severe causes of abdominal pain.
  26. [26]
    Hydronephrosis and Hydroureter Workup - Medscape Reference
    Oct 30, 2024 · Detection of antenatal hydronephrosis by ultrasound usually occurs in the second trimester. In this setting, hydronephrosis is defined as renal ...Missing: nuclear | Show results with:nuclear
  27. [27]
    Renal Ultrasound: Hydronephrosis and Stones
    Mar 4, 2022 · ... kidney. However, ultrasound is 90% sensitive for detecting the hydronephrosis which can be caused by ureteral stones. [5]. FIGURE 3: TWINKLE ...
  28. [28]
    Revised guidelines on management of antenatal hydronephrosis
    All patients with ANH should undergo postnatal ultrasonography; the intensity of subsequent evaluation depends on anteroposterior diameter (APD) of the renal ...
  29. [29]
    Hydronephrosis on Prior Imaging-Unknown Cause - AC Search
    A more comprehensive evaluation can often be achieved with CT, MRU, or renal scintigraphy. CT abdomen and pelvis without IV contrast is particularly useful when ...
  30. [30]
    Hydronephrosis and Upper Urinary Tract Obstruction: Differential ...
    Grading of Hydronephrosis. Grade I: dilatation of the renal pelvis \textit{without} dilatation of the calyces, no parenchymal atrophy. Grade II: dilatation ...
  31. [31]
    Acute Renal Colic - StatPearls - NCBI Bookshelf
    Ketorolac, an injectable NSAID commonly used for renal colic, is generally considered equivalent to or superior to opioids in treating acute ureterolithiasis ...
  32. [32]
    Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis ...
    Agents that are excreted in the urine but do not achieve therapeutic concentrations in the bloodstream, such as nitrofurantoin, should not be used to treat ...
  33. [33]
    Hydronephrosis and Hydroureter Treatment & Management
    Oct 30, 2024 · Treatment of hydronephrosis and hydroureter due to obstruction depends on the site and cause of obstruction.Approach Considerations · Medical Care · Surgical Care · Consultations
  34. [34]
    Percutaneous Nephrostomy | Treatment & Management | Point of Care
    May 4, 2025 · Percutaneous nephrostomy is a minimally invasive procedure used to drain the renal collecting system, typically in cases of urinary tract obstruction.<|control11|><|separator|>
  35. [35]
    Does degree of hydronephrosis affect success of extracorporeal ...
    The results of our study have shown that in patients with solitary distal ureter stones, the degree of hydronephrosis caused by the stone does not affect ...
  36. [36]
    Pyeloplasty: Purpose, Procedure, Risks & Recovery - Cleveland Clinic
    Pyeloplasty is surgery to correct ureteropelvic junction obstruction. A surgeon cuts out the blockage and reattaches your ureter to your kidney.
  37. [37]
    Transurethral resection of the prostate (TURP) - Mayo Clinic
    Mar 21, 2024 · Transurethral resection of the prostate (TURP) is a common surgery that's used to treat urinary problems that are caused by an enlarged prostate.Missing: hydronephrosis interventional lithotripsy ureterotomy
  38. [38]
    Endoscopic Management of Ureteral Stricture - NIH
    The most common endoscopic treatments for managing ureteral stricture disease are balloon dilation and endoureterotomy (generally with laser energy).
  39. [39]
    The challenging management of malignant ureteral obstruction - NIH
    The aims of this study are to analyze the causes, management, and survival of patients with obstructive nephropathy due to malignant ureteric obstruction.
  40. [40]
    Timing of posterior urethral valve diagnosis and its impact on clinical ...
    Sep 9, 2010 · Abstract. Objective: Our goals were to assess long-term outcome for patients with posterior urethral valves (PUV) and determine the impact ...
  41. [41]
    Obstructive uropathy: Overview of the pathogenesis, etiology and ...
    Jun 25, 2024 · If the obstructive period was prolonged for 14 d, renal recovery following decompression declined to 70% and to a further 30% if obstruction ...
  42. [42]
    Management of infected indwelling ureteral stents - PubMed Central
    To this day, there is no consensus or evidence to guide management of ureteral stents in infectious situations, which can range from UTI s to severe sepsis.Missing: early | Show results with:early
  43. [43]
    Impact of acute kidney injury on long-term adverse outcomes in ...
    Dec 8, 2021 · Short-term recovery was achieved in 56.78% after the relief of obstruction. ESKD progression rate was 4.4% in urolithiasis and 6.8% in other ...
  44. [44]
    Giant hydronephrosis: A rare cause of secondary hypertension
    Jul 9, 2025 · Hypertension secondary to giant hydronephrosis (GH) is a rare but treatable renal condition mediated by the renin-angiotensin-aldosterone system ...
  45. [45]
    Severe hydronephrosis complicated with primary aldosteronism
    Oct 6, 2024 · Severe hydronephrosis leads to renal parenchymal ischemia, resulting in increased renin secretion. ... secondary hypertension [1], and its ...
  46. [46]
    What is Hydronephrosis in Infants: Types, Symptoms & Treatment
    Poor growth or weight gain: Chronic or severe hydronephrosis may impact your child's overall growth and weight gain, potentially leading to slower growth or ...
  47. [47]
    Outcome of Neonatal Hydronephrosis, a New Cut-Off to Identify ...
    Nov 26, 2024 · Only 13 patients (2.6%) diagnosed with bilateral hydronephrosis had just unilateral resolution, and we managed them with the same criteria used ...Missing: rates | Show results with:rates
  48. [48]
    INTEGRATING PEDIATRIC UROLOGY AND NEPHROLOGY IN THE ...
    Sep 3, 2025 · Results: Integrated care improved diagnostic accuracy (91% vs. 72%, p<0.01) and reduced time-to-surgery for obstructive lesions (2.5 vs. 4.7 ...